Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag).
about
The Vpr protein from HIV-1: distinct roles along the viral life cycleVisualizing fusion of pseudotyped HIV-1 particles in real time by live cell microscopy.HIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchHIV-1 capsid: the multifaceted key player in HIV-1 infectionDistribution and Redistribution of HIV-1 Nucleocapsid Protein in Immature, Mature, and Integrase-Inhibited Virions: a Role for Integrase in MaturationThe DDB1-DCAF1-Vpr-UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destructionOptical trapping of individual human immunodeficiency viruses in culture fluid reveals heterogeneity with single-molecule resolution.Fluorescent protein-tagged Vpr dissociates from HIV-1 core after viral fusion and rapidly enters the cell nucleus.Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1.Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.Functional roles of equine infectious anemia virus Gag p9 in viral budding and infectionFormation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication.Visualization of the intracellular behavior of HIV in living cells.Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitroA protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.Human immunodeficiency virus type 1 N-terminal capsid mutants containing cores with abnormally high levels of capsid protein and virtually no reverse transcriptase.HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity.HIV-1 Vpr-a still "enigmatic multitasker".Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.Investigation of HIV-1 assembly and release using modern fluorescence imaging techniques.In vitro uncoating of HIV-1 cores.Role of Vif in stability of the human immunodeficiency virus type 1 coreBiochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag).Nucleic acid-independent retrovirus assembly can be driven by dimerization.Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein complex.Structural organization of authentic, mature HIV-1 virions and cores.Cell-free assays for HIV-1 uncoating.Reverse transcription complex: the key player of the early phase of HIV replication.Assembly properties of the human immunodeficiency virus type 1 CA protein.RNA control of HIV-1 particle size polydispersity.Resistance to pyridine-based inhibitor KF116 reveals an unexpected role of integrase in HIV-1 Gag-Pol proteolytic processing.Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages.Isolated HIV-1 core is active for reverse transcription.Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivitySolution structure of the human immunodeficiency virus type 1 p6 protein.
P2860
Q21245211-48ABCAB6-0086-481C-AE76-C5E11EEDBC4FQ22241754-43339EC2-5786-4B0E-B9DA-D490BE889C03Q26746070-E7794784-1959-4AA6-BE9B-75FBE31C42CAQ26801145-28B4EE55-971C-4348-91EC-73A730485F79Q27321347-2100B2DB-DA33-4F1C-9EFE-AE1248861FEEQ27727807-E66EF789-3B76-4300-8718-C2160B7892B9Q30586117-F97FF66B-BAB3-4189-92CD-A456AF6C7491Q30671100-078FBE23-0E03-4E7A-83CB-9EB0AA2EE162Q30843846-7C1C3CD6-3577-472C-8ACC-6A312C9E9DA6Q33791156-652A7B41-51DF-48BB-9390-4654F18F1EEEQ33826918-B1DF922F-8041-4544-814F-7DDFC8499170Q33845811-D6F151D2-53A5-4151-B1EF-943B84FF3C4BQ33846683-9E438BE4-32D0-40F1-9072-C9B6074A68C5Q34364648-8464E8A7-5219-462A-87BB-AF8BC888AF95Q36323740-AABB4639-C630-4D50-8DB7-3AE978408435Q36424184-27B5AC38-A519-4C41-923D-3B73E9075A4FQ36553297-D998F92C-77C5-4BAB-83E9-AF7196F49C2FQ36974763-E8BC8242-A924-49BC-BC14-EB440731398AQ37060306-45329EC6-A059-46C5-A11E-CDDF6E7908F3Q37447762-1993E403-EF8F-4A7C-833B-B2A4B3B2E4ABQ37689513-9A7EDE4C-9204-4DD0-9E8A-F924A9553E9BQ37950254-479DBB91-E1C6-42AE-8D29-FB677D233D94Q38041568-D7D852C8-C95B-4DE6-BAC8-89BB64146D08Q39439240-336D170C-FAB3-4A87-8A45-64B4DB568485Q39597709-A8C14DBE-C606-4FA1-AB2E-007D6C5517A2Q39604854-6C02626C-167F-46BC-A6B4-8F453DD9A44BQ39685711-E71698AA-571C-410C-87FD-0256FA3C5A62Q39696115-141988AD-47DB-4845-9A8C-E15FA8946425Q39736736-544D4A53-9D14-436D-9CA4-5322AA750F0CQ39744816-508915E8-EF62-4EC3-94A3-69EF035FE668Q39914308-2B9D145F-D80D-4712-8A7B-AE1EC6B01018Q40255729-01231A54-1CFF-4DD4-AE6C-DBF653142DEDQ40676680-49FA80F4-FAB4-4A24-9DEF-38B40B633A4FQ41890548-90BC3849-690F-427C-B9CD-EABC7B6129B3Q41925654-70A4342B-DEC2-48B1-9980-677478FC9B10Q41928771-F048B50D-C251-4B4B-A7EE-83D4FC2D43B0Q41956340-9D7551A0-61AB-4371-8BDA-99B407A926FAQ42125314-37417D5A-75BB-4B9F-B067-1E31DFE18D20Q44981187-6CF33A82-FD34-4D9C-A406-C11D472619B3
P2860
Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag).
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Isolation of human immunodefic ...... Vpr in the absence of p6(gag).
@ast
Isolation of human immunodefic ...... Vpr in the absence of p6(gag).
@en
type
label
Isolation of human immunodefic ...... Vpr in the absence of p6(gag).
@ast
Isolation of human immunodefic ...... Vpr in the absence of p6(gag).
@en
prefLabel
Isolation of human immunodefic ...... Vpr in the absence of p6(gag).
@ast
Isolation of human immunodefic ...... Vpr in the absence of p6(gag).
@en
P2093
P2860
P1433
P1476
Isolation of human immunodefic ...... Vpr in the absence of p6(gag).
@en
P2093
H G Göttlinger
M A Accola
P2860
P304
P356
10.1128/JVI.74.13.6198-6202.2000
P577
2000-07-01T00:00:00Z